Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2

[Image: see text] Covalently acting inhibitors constitute a large and growing fraction of approved small-molecule therapeutics as well as useful tools for a variety of in vitro and in vivo applications. Here, we aimed to develop a covalent antagonist of CC chemokine receptor 2 (CCR2), a class A GPCR...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Med Chem
Main Authors: Ortiz Zacarías, Natalia V., Chahal, Kirti K., Šimková, Tereza, van der Horst, Cas, Zheng, Yi, Inoue, Asuka, Theunissen, Emy, Mallee, Lloyd, van der Es, Daan, Louvel, Julien, IJzerman, Adriaan P., Handel, Tracy M., Kufareva, Irina, Heitman, Laura H.
Format: Artigo
Jezik:Inglês
Izdano: American Chemical Society 2021
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958898/
https://ncbi.nlm.nih.gov/pubmed/33600174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jmedchem.0c01137
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki